2019
DOI: 10.1186/s40104-019-0338-5
|View full text |Cite
|
Sign up to set email alerts
|

Myostatin gene promoter: structure, conservation and importance as a target for muscle modulation

Abstract: Myostatin (MSTN) is one of the key factors regulating myogenesis. Because of its role as a negative regulator of muscle mass deposition, much interest has been given to its protein and, in recent years, several studies have analysed MSTN gene regulation. This review discusses the MSTN gene promoter, focusing on its structure in several animal species, both vertebrate and invertebrate. We report the important binding sites considering their degree of phylogenetic co… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
32
0
5

Year Published

2020
2020
2025
2025

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 37 publications
(37 citation statements)
references
References 115 publications
(200 reference statements)
0
32
0
5
Order By: Relevance
“…MSTN is a member of the TGFβ family and acts as a phylogenetically conserved negative regulator of muscle mass [ 31 ]. The MSTN protein is synthesized mostly in muscle, adipose, and cardiac tissues, where it secreted and present as an extracellular matrix-resident [ 32 ]. The clinical relevance of myostatin is predominantly in treating muscle wasting diseases, obesity and type 2 diabetes [ 33 , 34 ].…”
Section: Resultsmentioning
confidence: 99%
“…MSTN is a member of the TGFβ family and acts as a phylogenetically conserved negative regulator of muscle mass [ 31 ]. The MSTN protein is synthesized mostly in muscle, adipose, and cardiac tissues, where it secreted and present as an extracellular matrix-resident [ 32 ]. The clinical relevance of myostatin is predominantly in treating muscle wasting diseases, obesity and type 2 diabetes [ 33 , 34 ].…”
Section: Resultsmentioning
confidence: 99%
“…The leucine effects on myostatin mRNA during immobilization could be related to transcription and posttranscriptional modulation. At transcriptional level, myostatin expression can be induced by the transcription factor FoxO (Allen and Unterman, 2007;Grade et al, 2019). Accordingly, FoxO activity is increased in disuse atrophy (Senf et al, 2010;Baptista et al, 2017) and leucine supplementation is able to decrease FoxO nuclear translocation during immobilization (Baptista et al, 2017).…”
mentioning
confidence: 99%
“…For example, follistatin mRNA could generate a currently uncharacterized microRNAs that would, in turn, be able to inhibit mRNAs coding for stimulators of myostatin, such as NF-kb-p65, MYOD, MYF5, and NFAT, all of which are known to be transactivators of the myostatin promoter. Alternatively, those microRNAs could even target myostatin mRNA itself (Huang et al, 2012;Qiu et al, 2013;Grade et al, 2019).…”
mentioning
confidence: 99%
“…Peningkatan otot ini merupakan hasil dari pengaruh MSTN terhadap gen-gen pengontrol siklus sel yang menyebabkan sel-sel progenitor myogenik secara permanen menarik diri dari siklus sel (Joulia et al 2003). Selain itu, MSTN merupakan penghambat proliferasi progenitor sel-sel otot rangka selama masa perkembangan hewan hingga saat terbentuknya ukuran otot rangka setelah lahir (Grade et al 2019).…”
Section: Gambar 1 Struktur Protein Myostatin Dan Mutasi Alamiunclassified